{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:03:53Z","timestamp":1767139433092,"version":"build-2238731810"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00101-015-0099-2","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T05:49:21Z","timestamp":1445233761000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Telefonische Anfragen zum Thema maligne Hyperthermie","Telephone enquiries on the topic of malignant hyperthermia"],"prefix":"10.1007","volume":"65","author":[{"given":"B.","family":"Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-D.","family":"Meinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"B\u00f6rge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kluba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. X.","family":"Kaisers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"R\u00fcffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD (1962) Anaesthetic deaths in a family. Br J Anaesth 34:395\u2013396","journal-title":"Br J Anaesth"},{"key":"99_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","volume":"107","author":"PM Hopkins","year":"2011","unstructured":"Hopkins PM (2011) Malignant hyperthermia: pharmacology of triggering. Br J Anaesth 107:48\u201356","journal-title":"Br J Anaesth"},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1566524023362429","volume":"2","author":"TE Nelson","year":"2002","unstructured":"Nelson TE (2002) Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med 2:347\u2013369","journal-title":"Curr Mol Med"},{"key":"99_CR4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","volume":"343","author":"TV McCarthy","year":"1990","unstructured":"McCarthy TV, Healy JM, Heffron JJ, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K (1990) Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343:562\u2013564","journal-title":"Nature"},{"key":"99_CR5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","volume":"60","author":"N Monnier","year":"1997","unstructured":"Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am Hum Genet 60:1316\u20131325","journal-title":"Am Hum Genet"},{"key":"99_CR6","doi-asserted-by":"crossref","first-page":"37471","DOI":"10.1074\/jbc.M701379200","volume":"282","author":"T Yang","year":"2007","unstructured":"Yang T, Allen PD, Pessah IN, Lopez JR (2007) Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem 282:37471\u201337478","journal-title":"J Biol Chem"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1016\/S0021-9258(19)76541-7","volume":"263","author":"JR Mickelson","year":"1988","unstructured":"Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF (1988) Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 263:9310\u20139315","journal-title":"J Biol Chem"},{"key":"99_CR8","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0006-3495(98)77684-2","volume":"75","author":"A Struk","year":"1998","unstructured":"Struk A, Lehmann-Horn F, Melzer W (1998) Voltage-dependent calcium release in human malignant hyperthermia muscle fibers. Biophys J 75:2402\u20132410","journal-title":"Biophys J"},{"key":"99_CR9","first-page":"w13652","volume":"142","author":"O Bandschapp","year":"2012","unstructured":"Bandschapp O, Girard T (2012) Malignant hyperthermia. Swiss Med Wkly 142:w13652","journal-title":"Swiss Med Wkly"},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N (2014) Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 118:381\u2013387","journal-title":"Anesth Analg"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K (2007) Malignant hyperthermia. Orphanet J Rare Dis 2:21","journal-title":"Orphanet J Rare Dis"},{"key":"99_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KP Glahn","year":"2010","unstructured":"Glahn KP, Ellis FR, Halsall PJ, M\u00fcller CR, Snoeck MM, Urwyler A, Wappler F, European Malignant Hyperthermia Group (2010) Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 105:417\u2013420","journal-title":"Br J Anaesth"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1100\/tsw.2006.289","volume":"6","author":"BW Brandom","year":"2006","unstructured":"Brandom BW (2006) Genetics of malignant hyperthermia. ScientificWorldJournal 6:1722\u20131730","journal-title":"ScientificWorldJournal"},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1213\/00000539-199705000-00016","volume":"84","author":"MR Weglinski","year":"1997","unstructured":"Weglinski MR, Wedel DJ, Engel AG (1997) Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 84:1038\u20131041","journal-title":"Anesth Analg"},{"key":"99_CR15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.23633","volume":"47","author":"S Johannsen","year":"2013","unstructured":"Johannsen S, Berberich C, Metterlein T, Roth C, Reiners K, Roewer N, Schuster F (2013) Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study. Muscle Nerve 47:677\u2013681","journal-title":"Muscle Nerve"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/ALN.0b013e3181862a0d","volume":"109","author":"A Malandrini","year":"2008","unstructured":"Malandrini A, Orrico A, Gaudiano C, Gambelli S, Galli L, Berti G, Tegazzin V, Dotti MT, Federico A, Sorrentino V (2008) Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia. Anesthesiology 109:625\u2013628","journal-title":"Anesthesiology"},{"key":"99_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/15563658708992619","volume":"25","author":"KS Merigian","year":"1987","unstructured":"Merigian KS, Roberts JR (1987) Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 25:135\u2013148","journal-title":"J Toxicol Clin Toxicol"},{"key":"99_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","volume":"94","author":"F Wappler","year":"2001","unstructured":"Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S, Matschke J, Schulte Am Esch J (2001) Evidence for susceptibility. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 94:95\u2013100","journal-title":"Anesthesiology"},{"key":"99_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/EJA.0b013e32835a1127","volume":"30","author":"JK Sch\u00fctte","year":"2013","unstructured":"Sch\u00fctte JK, Sch\u00e4fer U, Becker S, Oldewurtel C, Starosse A, Singler P, Richard A, Wappler F, Gerbershagen MU (2013) 3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia. Eur J Anaesthesiol 30:29\u201337","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"99_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-2007-994238","volume":"33","author":"E Hartung","year":"1998","unstructured":"Hartung E, Anetseder M, Olthoff D, Deutrich C, Lehmann-Horn F, Baur C, Mortier W, Tzanova I, Doetsch S, Quasthoff S, Hofmann M, Schwefler B, Jantzen JP, Wappler F, Scholz J (1998) Regional distribution of predisposition to maligant hyperthermia in Germany: State in 1997. Anasthesiol Intensivmed Notfallmed Schmerzther 33(4):238\u2013243","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00101-014-2351-6","volume":"63","author":"S Wolak","year":"2014","unstructured":"Wolak S, R\u00fccker B, Kohlschmidt N, Doetsch S, Bartsch O, Zechner U, Tzanova I (2014) Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia. Anaesthesist 63:643\u2013650","journal-title":"Anaesthesist"},{"key":"99_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/cc13744","volume":"18","author":"F Schuster","year":"2014","unstructured":"Schuster F, Moegele S, Johannsen S, Roewer N (2014) Malignant hyperthermia in the intensive care setting. Crit Care 18:411","journal-title":"Crit Care"},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1213\/ane.0b013e3181b493d4","volume":"109","author":"PJ Davis","year":"2009","unstructured":"Davis PJ, Brandom BW (2009) The association of malignant hyperthermia and unusual disease: when you\u2019re hot you\u2019re hot or maybe not. Anesth Analg 109:1001\u20131003","journal-title":"Anesth Analg"},{"key":"99_CR24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1213\/ANE.0b013e3181b5ae2d","volume":"109","author":"W Klingler","year":"2009","unstructured":"Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins PM (2009) Core myopathies and risk of malignant hyperthermia. Anesth Analg 109:1167\u20131173","journal-title":"Anesth Analg"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","volume":"109","author":"J Parness","year":"2009","unstructured":"Parness J, Bandschapp O, Girard T (2009) The myotonias and susceptibility to malignant hyperthermia. Anesth Analg 109:1054\u20131064","journal-title":"Anesth Analg"},{"key":"99_CR26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","volume":"56","author":"o","year":"1984","unstructured":"European Malignant Hyperthermia Group (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. Br J Anaesth 56:1267\u20131269","journal-title":"Br J Anaesth"},{"key":"99_CR27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"A Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S, European Malignant Hyperthermia Group (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 86:283\u2013287","journal-title":"Br J Anaesth"},{"key":"99_CR28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P (2006) Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 27:977\u2013989","journal-title":"Hum Mutat"},{"key":"99_CR29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","volume":"102","author":"N Sambuughin","year":"2005","unstructured":"Sambuughin N, Holley H, Muldoon S, Brandom BW, de Bantel AM, Tobin JR, Nelson TE, Goldfarb LG (2005) Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population. Anesthesiology 102:515\u2013521","journal-title":"Anesthesiology"},{"key":"99_CR30","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00173.2004","volume":"287","author":"RG Weiss","year":"2004","unstructured":"Weiss RG, O\u2019Connell KM, Flucher BE, Allen PD, Grabner M, Dirksen RT (2004) Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol 287:C1094\u2013C1102","journal-title":"Am J Physiol Cell Physiol"},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1073\/pnas.1119207109","volume":"109","author":"JM Eltit","year":"2012","unstructured":"Eltit JM, Bannister RA, Moua O, Altamirano F, Hopkins PM, Pessah IN, Molinski TF, Lopez JR, Beam KG, Allen PD (2012) Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2 + channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A 109:7923\u20137928","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, R\u00fcffert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, M\u00fcller CR, Urwyler A, European Malignant Hyperthermia Group (2015) European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 115:531\u2013539. (pii: aev225)","journal-title":"Br J Anaesth"},{"key":"99_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJMsa1204720","volume":"368","author":"AF Arriaga","year":"2013","unstructured":"Arriaga AF, Bader AM, Wong JM, Lipsitz SR, Berry WR, Ziewacz JE, Hepner DL, Boorman DJ, Pozner CN, Smink DS, Gawande AA (2013) Simulation-based trial of surgical-crisis checklists. N Engl J Med 368:246\u2013253","journal-title":"N Engl J Med"},{"key":"99_CR34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P, Reyford H, Lunardi J (2002) Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 97:1067\u20131074","journal-title":"Anesthesiology"},{"key":"99_CR35","first-page":"700","volume":"64","author":"H Ording","year":"1985","unstructured":"Ording H (1985) Incidence of malignant hyperthermia in Denmark. Anesth Analg 64:700\u2013704","journal-title":"Anesth Analg"},{"key":"99_CR36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00101-007-1218-5","volume":"56","author":"H R\u00fcffert","year":"2007","unstructured":"R\u00fcffert H, Wehner M, Deutrich C, Olthoff D (2007) Malignant hyperthermia: the ugly. Anaesthesist 56:923\u2013929","journal-title":"Anaesthesist"}],"updated-by":[{"DOI":"10.1007\/s00101-018-0427-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000}}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-015-0099-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-015-0099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-015-0099-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-015-0099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:22:05Z","timestamp":1653308525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-015-0099-2"}},"subtitle":["Auswertung der Inhalte und der resultierenden Diagnostikergebnisse am MH-Zentrum Leipzig","Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig"],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s00101-015-0099-2","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}